If you have primary mediastinal B-cell lymphoma (PMBL), you’ve likely heard about CAR T gene therapy. There’s good reason for that. Loretta Nastoupil, MD, will tell you, “It’s just the most exciting ...

PURPOSE: Primary mediastinal B-cell lymphoma (PMBL) is recognized as a separate disease entity in the REAL classification. There is uncertainty about the relevance and especially the optimal ...

Even though it’s one of the latest and greatest cancer treatments, CAR T therapy still has its side effects. They’re often mild, but they can be serious and affect your heart, kidneys, and brain. That ...

Primary mediastinal B-cell lymphoma (PMBL) is an aggressive extranodal B-cell non-Hodgkin's lymphoma with specific clinical, histopathological and genomic features. To characterize further the ...

Diagnosis of PMBL using clinical and morphological features alone is imprecise, leading to an uncertain prognosis. Both research groups have devised a molecular signature to identify PMBLs and ...

This study looked at tissue samples and PET scans to learn more about ‘primary mediastinal diffuse large B cell lymphoma’ (PMBL) and the best way to treat it. Cancer Research UK supported this study.